<DOC>
	<DOC>NCT00273429</DOC>
	<brief_summary>To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.</brief_summary>
	<brief_title>Cosopt Versus Xalatan</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>adults with primary openangle, pigmentary, or exfoliation glaucoma, or ocular hypertenstion intraocular pressure should be 22 to 30 mm Hg inclusive on timolol BID at the 08:00 H ETDRS visual acuity must be 1.0 or better in both eyes any contraindications to study medications any anticipated change in systemic hypertensive therapy during the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>